According to researchers at Cornell, a newly discovered small molecule could be used in nasal sprays which will help to prevent COVID-19 illness before exposure and provide early treatment if taken after infection. The spray attempts to block the entry of the virus while other treatments concentrate on decreasing its replication.
EBVIA Therapeutics is now currently raising funds for testing. Such a treatment holds potential for preventing and reducing COVID-19 with a few single daily doses.